The association between sarcopenia and quality of life in patients undergoing colorectal cancer surgery: an exploratory study
- PMID: 33547963
- DOI: 10.1007/s00520-021-06025-y
The association between sarcopenia and quality of life in patients undergoing colorectal cancer surgery: an exploratory study
Erratum in
-
Correction to: The association between sarcopenia and quality of life in patients undergoing colorectal cancer surgery: an exploratory study.Support Care Cancer. 2021 Jun;29(6):3421. doi: 10.1007/s00520-021-06096-x. Support Care Cancer. 2021. PMID: 33619676 No abstract available.
Abstract
Objective: To describe changes in health-related quality of life (QoL) from before colorectal cancer (CRC) surgery to 1 and 3-month post-surgery in patients diagnosed pre-operatively as sarcopenic or non-sarcopenic by computed tomography (CT) analysis.
Methods: Secondary analysis of a prospective observational cohort study with one pre-operative and two post-operative assessments. Patient-reported outcome measures (PROMs) were collected at each timepoint using Functional Assessment of Cancer Therapy-Colorectal and the EuroQol-5D (EQ-5D) questionnaires. Pre-operative staging CT scans of the third lumbar vertebra (axial slice) were analysed using Slice-O-Matic Software to determine if patients had CT defined sarcopenia by employing sex-specific threshold values for skeletal muscle index. Patient-reported outcome measure scores were compared with minimal clinical important difference estimates to determine if changes were clinically significant.
Results: Twenty-five of 40 patients were found to be sarcopenic. The difference between sarcopenic groups on the EQ-5D was medium-sized and clinically significant, with the sarcopenic group reporting lower health status. The non-sarcopenic group displayed a clinically significant reduction in physical wellbeing post-operatively. The sarcopenic group did not demonstrate a clinically important reduction in physical wellbeing. For functional wellbeing, the sarcopenic group recorded a clinically significant reduction at the 1-month timepoint, trending back towards baseline by the 3-month timepoint. The non-sarcopenic group recorded almost no change in functional scores.
Conclusion: This study explored the novel concept of the effect of sarcopenia on QoL in the CRC surgical setting. Clinically significant changes were identified at both post-operative timepoints. This highlights an important proof of concept that PROMs can detect meaningful clinical change in CRC patients in the context of sarcopenia and should be further explored.
Keywords: Colorectal cancer; Quality of life; Sarcopenia; Surgery.
References
-
- Feletto E, Yu XQ, Lew J-B, St John DJB, Jenkins MA, Macrae FA et al (2019) Trends in colon and rectal cancer incidence in Australia from 1982 to 2014: analysis of data on over 375,000 cases. Cancer Epidemiol Prev Biomark 28(1):83–90 - DOI
-
- Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RG, Barzi A et al (2017) Colorectal cancer statistics, 2017. CA Cancer J Clin 67(3):177–193 - DOI
-
- Koller M, Lorenz W (2002) Quality of life: a deconstruction for clinicians. J R Soc Med 95(10):481–488 - DOI
-
- Zerillo JA, Schouwenburg MG, van Bommel AC, Stowell C, Lippa J, Bauer D et al (2017) An international collaborative standardizing a comprehensive patient-centered outcomes measurement set for colorectal cancer. JAMA Oncol 3(5):686–694 - DOI
-
- Black N (2013) Patient reported outcome measures could help transform healthcare. BMJ. 346
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
